APA
BBC icon

American Portfolios Advisors’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

American Portfolios Advisors’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-133
Closed -$5.18K – 2989
2020
Q3 		$5.18K Buy
+133
New +$5.42K ﹤0.01% 2271

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FEM
Fulcrum Equity Management Plano, Texas $136M AUM 42.95% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

American Portfolios Advisors's BBC Position: Q4 2020 in Review

American Portfolios Advisors sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q4 2020, closing a stake of 133 shares — an estimated $5.18K sold.

American Portfolios Advisors first reported a position in BBC in Q3 2020 and held it in 1 quarter. The position peaked at $5.18K in Q3 2020. 21 funds tracked by Wall St. Rank hold BBC as of Q4 2020.

  • American Portfolios Advisors reported no remaining Virtus Biotech Clinical Trials ETF position as of Q4 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 133 Virtus Biotech Clinical Trials ETF shares in Q4 2020, an estimated $5.18K.
  • American Portfolios Advisors first reported a position in Virtus Biotech Clinical Trials ETF in Q3 2020 and held it in 1 quarter.
  • American Portfolios Advisors's Virtus Biotech Clinical Trials ETF position peaked at $5.18K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2020.

Based on American Portfolios Advisors's 13F filing for Q4 2020, filed 22 Mar 2023.